25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

biOasis Technologies Inc
Buy, Hold or Sell?

Let's analyze Bioasis together

I guess you are interested in biOasis Technologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of biOasis Technologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about biOasis Technologies Inc

I send you an email if I find something interesting about biOasis Technologies Inc.

1. Quick Overview

1.1. Quick analysis of Bioasis (30 sec.)










1.2. What can you expect buying and holding a share of Bioasis? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.02
Expected worth in 1 year
$-0.02
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bioasis (5 min.)




Live pricePrice per Share (EOD)
$0.00

2.2. Growth of Bioasis (5 min.)




Is Bioasis growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.3m-$1.3m0.000.0%

How much money is Bioasis making?

Current yearPrevious yearGrowGrow %
Making money0.00-$2.1m$2.1m?
Net Profit Margin0.0%-7,846.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Bioasis (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bioasis?

Welcome investor! Bioasis's management wants to use your money to grow the business. In return you get a share of Bioasis.

First you should know what it really means to hold a share of Bioasis. And how you can make/lose money.

Speculation

The Price per Share of Bioasis is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioasis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioasis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.02. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioasis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.000.0%0.000.0%-0.03-26,501.9%-0.02-17,532.8%-0.02-23,446.3%
Usd Book Value Change Per Share0.000.0%0.000.0%-0.02-20,812.0%0.00-4,210.6%0.00-4,934.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%-0.02-20,812.0%0.00-4,210.6%0.00-4,934.4%
Usd Price Per Share0.01-0.01-0.21-0.21-0.50-
Price to Earnings Ratio0.00-0.00--7.89-4.93--12.94-
Price-to-Total Gains Ratio-10.04--11.55-0.23-
Price to Book Ratio-0.82--0.82--12.18--1.22-50.15-
Price-to-Total Gains Ratio-10.04--11.55-0.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10000000 shares)0.00-42,106.48
Gains per Year (10000000 shares)0.00-168,425.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
100-100-168426-168436
200-100-336852-336862
300-100-505278-505288
400-100-673704-673714
500-100-842130-842140
600-100-1010556-1010566
700-100-1178982-1178992
800-100-1347408-1347418
900-100-1515833-1515844
1000-100-1684259-1684270

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.00.01.00.0%1.02.01.025.0%1.03.01.020.0%1.08.01.010.0%1.015.01.05.9%
Book Value Change Per Share0.00.01.00.0%1.02.01.025.0%1.03.01.020.0%2.07.01.020.0%7.09.01.041.2%
Dividend per Share0.00.01.00.0%0.00.04.00.0%0.00.05.00.0%0.00.010.00.0%0.00.017.00.0%
Total Gains per Share0.00.01.00.0%1.02.01.025.0%1.03.01.020.0%2.07.01.020.0%7.09.01.041.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of biOasis Technologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%-0.0210%-0.0040%-0.0050%
Book Value Per Share---0.017-0.0170%-0.0170%-0.012-33%0.000-4338%
Current Ratio----0%0.705-100%0.735-100%2.899-100%
Debt To Asset Ratio--1.8461.8460%1.8460%1.904-3%1.121+65%
Debt To Equity Ratio--10.27310.2730%-+100%3.464+197%2.162+375%
Dividend Per Share----0%-0%-0%-0%
Eps----0%-0.0270%-0.0180%-0.0230%
Gross Profit Margin----0%1.000-100%0.800-100%0.900-100%
Market Cap7941.400-13900%1111796.0001111796.0000%16597526.000-93%16335459.800-93%39882504.940-97%
Net Profit Margin----0%-78.4650%-17.4850%-10.9230%
Operating Margin----0%-95.3420%-21.4470%-12.8810%
Operating Ratio----0%97.798-100%22.403-100%13.673-100%
Pb Ratio-0.006+99%-0.816-0.8160%-12.175+1393%-1.221+50%50.155-102%
Pe Ratio----0%-7.8860%4.929-100%-12.9450%
Price Per Share0.000-13900%0.0140.0140%0.209-93%0.206-93%0.502-97%
Price To Free Cash Flow Ratio----0%-6.4210%-0.9710%-23.7630%
Quick Ratio----0%0.612-100%0.678-100%3.498-100%
Return On Assets----0%-1.3060%-1.4790%-1.8310%
Return On Equity----0%-0%0.343-100%-2.3160%
Total Gains Per Share----0%-0.0210%-0.0040%-0.0050%
Usd Book Value---1363244.382-1363244.3820%-1363244.3820%-918677.696-33%32165.711-4338%
Usd Book Value Change Per Share----0%-0.0210%-0.0040%-0.0050%
Usd Book Value Per Share---0.017-0.0170%-0.0170%-0.012-33%0.000-4338%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps----0%-0.0270%-0.0180%-0.0230%
Usd Free Cash Flow----0%-2584844.0550%-1193686.2400%-1407238.1470%
Usd Market Cap7941.400-13900%1111796.0001111796.0000%16597526.000-93%16335459.800-93%39882504.940-97%
Usd Price Per Share0.000-13900%0.0140.0140%0.209-93%0.206-93%0.502-97%
Usd Profit----0%-2104625.4120%-1392353.5750%-1927489.0760%
Usd Revenue----0%26822.475-100%873714.910-100%541511.962-100%
Usd Total Gains Per Share----0%-0.0210%-0.0040%-0.0050%
 EOD+1 -4MRQTTM+0 -0YOY+2 -95Y+4 -1310Y+3 -12

3.3 Fundamental Score

Let's check the fundamental score of biOasis Technologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Book Ratio (EOD)Between0-1-0.006
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than11.846
Debt to Equity Ratio (MRQ)Less than110.273
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total0/9 (0.0%)

3.4 Technical Score

Let's check the technical score of biOasis Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.795
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About biOasis Technologies Inc

Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). It has research collaborations with Aposense Limited to focus on the delivery of siRNA therapeutics for CNS disorders; Oxyrane UK Ltd. to focus on combining xB3 technology and Oxyrane's OxyCAT platform to deliver an undisclosed enhanced enzyme replacement therapy into the brain; and Janssen Biotech, Inc. to research, develop, and commercialize novel products based on Bioasis' xB3 platform. The company also has a research collaboration and license agreement with Neuramedy Co Ltd. to research, develop, and commercialize an xB3TM version of its antibody, Tomaralimab. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut.

Fundamental data was last updated by Penke on 2024-11-27 18:36:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Bioasis earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of biOasis Technologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-7,846.5%+7,846.5%
TTM-5Y-1,748.5%+1,748.5%
5Y-1,748.5%10Y-1,092.3%-656.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--112.2%+112.2%
TTM--221.4%+221.4%
YOY-7,846.5%-210.0%-7,636.5%
5Y-1,748.5%-342.2%-1,406.3%
10Y-1,092.3%-464.5%-627.8%
4.3.1.2. Return on Assets

Shows how efficient Bioasis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • 0.0% Return on Assets means that Bioasis generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of biOasis Technologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-130.6%+130.6%
TTM-5Y-147.9%+147.9%
5Y-147.9%10Y-183.1%+35.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.3%+11.3%
TTM--11.7%+11.7%
YOY-130.6%-11.3%-119.3%
5Y-147.9%-12.7%-135.2%
10Y-183.1%-14.1%-169.0%
4.3.1.3. Return on Equity

Shows how efficient Bioasis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • 0.0% Return on Equity means Bioasis generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of biOasis Technologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y34.3%-34.3%
5Y34.3%10Y-231.6%+265.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.2%+14.2%
TTM--15.9%+15.9%
YOY--14.3%+14.3%
5Y34.3%-18.5%+52.8%
10Y-231.6%-19.3%-212.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of biOasis Technologies Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Bioasis is operating .

  • Measures how much profit Bioasis makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of biOasis Technologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-9,534.2%+9,534.2%
TTM-5Y-2,144.7%+2,144.7%
5Y-2,144.7%10Y-1,288.1%-856.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--222.9%+222.9%
TTM--310.7%+310.7%
YOY-9,534.2%-223.5%-9,310.7%
5Y-2,144.7%-387.1%-1,757.6%
10Y-1,288.1%-498.5%-789.6%
4.3.2.2. Operating Ratio

Measures how efficient Bioasis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of biOasis Technologies Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY97.798-97.798
TTM-5Y22.403-22.403
5Y22.40310Y13.673+8.730
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.465-2.465
TTM-3.253-3.253
YOY97.7983.298+94.500
5Y22.4034.788+17.615
10Y13.6736.494+7.179
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of biOasis Technologies Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bioasis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of biOasis Technologies Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.705-0.705
TTM-5Y0.735-0.735
5Y0.73510Y2.899-2.164
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.637-3.637
TTM-3.890-3.890
YOY0.7054.666-3.961
5Y0.7355.953-5.218
10Y2.8996.277-3.378
4.4.3.2. Quick Ratio

Measures if Bioasis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of biOasis Technologies Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.612-0.612
TTM-5Y0.678-0.678
5Y0.67810Y3.498-2.820
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.086-3.086
TTM-3.451-3.451
YOY0.6124.456-3.844
5Y0.6785.931-5.253
10Y3.4986.436-2.938
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of biOasis Technologies Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Bioasis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bioasis to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.85 means that Bioasis assets are financed with 184.6% credit (debt) and the remaining percentage (100% - 184.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of biOasis Technologies Inc:

  • The MRQ is 1.846. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.846. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.846TTM1.8460.000
TTM1.846YOY1.8460.000
TTM1.8465Y1.904-0.058
5Y1.90410Y1.121+0.784
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8460.350+1.496
TTM1.8460.344+1.502
YOY1.8460.310+1.536
5Y1.9040.365+1.539
10Y1.1210.382+0.739
4.5.4.2. Debt to Equity Ratio

Measures if Bioasis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • A Debt to Equity ratio of 1,027.3% means that company has $10.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of biOasis Technologies Inc:

  • The MRQ is 10.273. The company is unable to pay all its debts with equity. -1
  • The TTM is 10.273. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ10.273TTM10.2730.000
TTM10.273YOY-+10.273
TTM10.2735Y3.464+6.809
5Y3.46410Y2.162+1.301
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.2730.394+9.879
TTM10.2730.432+9.841
YOY-0.380-0.380
5Y3.4640.451+3.013
10Y2.1620.490+1.672
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bioasis generates.

  • Above 15 is considered overpriced but always compare Bioasis to the Biotechnology industry mean.
  • A PE ratio of 0.00 means the investor is paying $0.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of biOasis Technologies Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-7.886+7.886
TTM-5Y4.929-4.929
5Y4.92910Y-12.945+17.874
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--2.411+2.411
TTM--3.149+3.149
YOY-7.886-3.274-4.612
5Y4.929-6.143+11.072
10Y-12.945-6.785-6.160
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of biOasis Technologies Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-6.421+6.421
TTM-5Y-0.971+0.971
5Y-0.97110Y-23.763+22.793
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.259+3.259
TTM--3.730+3.730
YOY-6.421-4.574-1.847
5Y-0.971-8.371+7.400
10Y-23.763-9.287-14.476
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Bioasis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.82 means the investor is paying $-0.82 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of biOasis Technologies Inc:

  • The EOD is -0.006. Based on the equity, the company is expensive. -2
  • The MRQ is -0.816. Based on the equity, the company is expensive. -2
  • The TTM is -0.816. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.006MRQ-0.816+0.810
MRQ-0.816TTM-0.8160.000
TTM-0.816YOY-12.175+11.359
TTM-0.8165Y-1.221+0.406
5Y-1.22110Y50.155-51.376
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0061.979-1.985
MRQ-0.8162.051-2.867
TTM-0.8162.365-3.181
YOY-12.1752.455-14.630
5Y-1.2213.726-4.947
10Y50.1554.378+45.777
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-02-28. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Current Assets
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Common Stock Shares Outstanding 78,213



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2023-02-282022-02-282021-02-282020-02-292019-02-282018-02-282017-02-282016-02-292015-02-282014-02-282013-02-282012-02-292011-02-282010-02-282009-02-282008-02-292007-02-28
> Total Assets 
90
631
2,093
3,034
2,543
2,148
3,835
2,579
2,212
2,153
1,111
1,222
1,743
942
3,276
2,266
0
02,2663,2769421,7431,2221,1112,1532,2122,5793,8352,1482,5433,0342,09363190
   > Total Current Assets 
90
503
926
1,974
1,577
1,106
3,250
2,047
1,730
1,723
731
793
1,382
652
3,059
2,107
0
02,1073,0596521,3827937311,7231,7302,0473,2501,1061,5771,97492650390
       Cash And Cash Equivalents 
90
1
877
1,693
1,488
1,047
1,695
1,092
1,339
773
554
678
1,360
576
2,737
1,731
0
01,7312,7375761,3606785547731,3391,0921,6951,0471,4881,693877190
       Short-term Investments 
0
480
0
0
0
0
1,500
750
300
850
0
0
0
0
0
0
0
00000008503007501,50000004800
       Net Receivables 
0
7
30
38
67
43
35
137
14
30
58
34
10
13
30
98
0
09830131034583014137354367383070
       Other Current Assets 
0
0
0
0
0
0
19
61
20
70
119
82
13
62
292
278
0
027829262138211970206119000000
   > Long-term Assets 
0
128
1,167
1,061
966
1,042
585
532
481
430
380
428
361
290
217
159
0
01592172903614283804304815325851,0429661,0611,1671280
       Property Plant Equipment 
0
0
5
5
16
13
13
9
7
5
3
42
33
21
5
0
0
00521334235791313165500
       Intangible Assets 
0
0
1,162
1,056
949
1,029
572
523
474
425
376
387
328
269
213
159
0
01592132693283873764254745235721,0299491,0561,16200
> Total Liabilities 
5
57
21
39
120
161
241
188
207
434
748
788
2,290
3,428
2,869
4,183
0
04,1832,8693,4282,2907887484342071882411611203921575
   > Total Current Liabilities 
5
57
21
39
116
159
241
186
207
434
748
788
1,263
2,477
1,899
2,989
0
02,9891,8992,4771,2637887484342071862411591163921575
       Short-term Debt 
0
0
0
0
0
0
0
0
0
321
17
0
0
486
56
1,500
0
01,500564860017321000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
486
56
1,500
0
01,500564860000000000000
       Accounts payable 
0
57
0
0
0
0
232
167
164
321
574
788
999
1,991
1,843
1,489
0
01,4891,8431,9919997885743211641672320000570
       Other Current Liabilities 
0
0
0
0
0
0
2
2
1
321
174
0
264
0
0
0
0
00002640174321122000000
   > Long-term Liabilities 
0
0
0
0
4
2
0
1
0
0
0
0
1,027
951
970
1,194
0
01,1949709511,027000010240000
       Other Liabilities 
0
0
0
0
0
0
0
1
0
0
0
0
1,027
433
912
792
0
07929124331,027000010000000
> Total Stockholder Equity
85
574
2,072
2,995
2,423
1,987
3,594
2,391
2,005
1,719
363
434
-547
-2,486
407
-1,917
0
0-1,917407-2,486-5474343631,7192,0052,3913,5941,9872,4232,9952,07257485
   Common Stock
90
0
0
0
0
0
12,452
13,248
13,357
18,363
18,649
22,791
24,199
25,418
27,258
27,454
0
027,45427,25825,41824,19922,79118,64918,36313,35713,24812,4520000090
   Retained Earnings 0-40,654-37,694-38,392-34,336-30,862-25,555-22,564-19,991-17,155-13,544-8,584-5,646-3,504-1,286-136-5
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
710
3,357
6,499
8,069
10,571
17,138
19,545
21,996
5,920
7,269
8,475
9,595
10,471
10,658
11,098
0
011,09810,65810,4719,5958,4757,2695,92021,99619,54517,13810,5718,0696,4993,3577100



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-02-28. All numbers in thousands.

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = 0
0
0
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-0
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Bioasis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bioasis. The general trend of Bioasis is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bioasis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of biOasis Technologies Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
biOasis Technologies Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of biOasis Technologies Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

biOasis Technologies Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of biOasis Technologies Inc. The current macd is 0.00000.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bioasis price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bioasis. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bioasis price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
biOasis Technologies Inc Daily Moving Average Convergence/Divergence (MACD) ChartbiOasis Technologies Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of biOasis Technologies Inc. The current adx is 28.41.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bioasis shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
biOasis Technologies Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of biOasis Technologies Inc. The current sar is 0.00203126.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
biOasis Technologies Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of biOasis Technologies Inc. The current rsi is 35.80. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
biOasis Technologies Inc Daily Relative Strength Index (RSI) ChartbiOasis Technologies Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of biOasis Technologies Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bioasis price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
biOasis Technologies Inc Daily Stochastic Oscillator ChartbiOasis Technologies Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of biOasis Technologies Inc. The current cci is -66.66666667.

biOasis Technologies Inc Daily Commodity Channel Index (CCI) ChartbiOasis Technologies Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of biOasis Technologies Inc. The current cmo is -35.69560972.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
biOasis Technologies Inc Daily Chande Momentum Oscillator (CMO) ChartbiOasis Technologies Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of biOasis Technologies Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
biOasis Technologies Inc Daily Williams %R ChartbiOasis Technologies Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of biOasis Technologies Inc.

biOasis Technologies Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of biOasis Technologies Inc. The current atr is 0.00000.

biOasis Technologies Inc Daily Average True Range (ATR) ChartbiOasis Technologies Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of biOasis Technologies Inc. The current obv is -4,421,800.

biOasis Technologies Inc Daily On-Balance Volume (OBV) ChartbiOasis Technologies Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of biOasis Technologies Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
biOasis Technologies Inc Daily Money Flow Index (MFI) ChartbiOasis Technologies Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for biOasis Technologies Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-24MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

biOasis Technologies Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of biOasis Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.795
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bioasis with someone you think should read this too:
  • Are you bullish or bearish on Bioasis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bioasis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about biOasis Technologies Inc

I send you an email if I find something interesting about biOasis Technologies Inc.


Comments

How you think about this?

Leave a comment

Stay informed about biOasis Technologies Inc.

Receive notifications about biOasis Technologies Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.